Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Goodwill & Intangibles (2016 - 2025)

STRATA Skin Sciences' Goodwill & Intangibles history spans 14 years, with the latest figure at $5.7 million for Q3 2025.

  • For Q3 2025, Goodwill & Intangibles fell 51.01% year-over-year to $5.7 million; the TTM value through Sep 2025 reached $5.7 million, down 51.01%, while the annual FY2024 figure was $6.8 million, 3.96% up from the prior year.
  • Goodwill & Intangibles for Q3 2025 was $5.7 million at STRATA Skin Sciences, down from $5.8 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $27.6 million in Q2 2022 and bottomed at $1.4 million in Q1 2025.
  • The 5-year median for Goodwill & Intangibles is $11.5 million (2024), against an average of $13.5 million.
  • The largest annual shift saw Goodwill & Intangibles soared 189.41% in 2023 before it plummeted 88.59% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $18.9 million in 2021, then surged by 38.71% to $26.2 million in 2022, then plummeted by 75.12% to $6.5 million in 2023, then increased by 3.96% to $6.8 million in 2024, then fell by 16.6% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Goodwill & Intangibles are $5.7 million (Q3 2025), $5.8 million (Q2 2025), and $1.4 million (Q1 2025).